We are live on ! Find out more
BCIM

British Columbia Investment Management Portfolio holdings

AUM $17B
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
+31.69%
3 Year Est. Return
+89.35%
5 Year Est. Return
+112.26%
10 Year Est. Return
+424.53%
AUM
$12.2B
AUM Growth
+$1.72B
Cap. Flow
+$440M
Cap. Flow %
3.59%
Top 10 Hldgs %
28.42%
Holding
818
New
13
Increased
655
Reduced
94
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 24.98%
2 Financials 16.34%
3 Consumer Discretionary 10.18%
4 Industrials 9.78%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
276
DexCom
DXCM
$34.3B
$5.54M 0.05%
44,657
+9,414
+27% +$962K
CARR icon
277
Carrier Global
CARR
$52B
$5.54M 0.05%
96,428
+20,490
+27% +$1.08M
F icon
278
Ford
F
$55.1B
$5.52M 0.05%
452,520
+94,949
+27% +$1.06M
KKR icon
279
KKR & Co
KKR
$99.5B
$5.48M 0.04%
66,187
+11,263
+21% +$763K
HLT icon
280
Hilton Worldwide
HLT
$72.6B
$5.48M 0.04%
30,103
+6,023
+25% +$983K
NEM icon
281
Newmont
NEM
$124B
$5.45M 0.04%
131,601
+59,330
+82% +$2.29M
SRE icon
282
Sempra
SRE
$56.2B
$5.41M 0.04%
72,454
+15,236
+27% +$1.09M
ROST icon
283
Ross Stores
ROST
$79.6B
$5.39M 0.04%
38,984
+7,981
+26% +$994K
WELL icon
284
Welltower
WELL
$166B
$5.38M 0.04%
59,711
+14,525
+32% +$1.26M
SPG icon
285
Simon Property Group
SPG
$71.4B
$5.37M 0.04%
37,663
+7,927
+27% +$958K
AFL icon
286
Aflac
AFL
$60.5B
$5.36M 0.04%
64,977
+12,777
+24% +$1.03M
EW icon
287
Edwards Lifesciences
EW
$53.6B
$5.34M 0.04%
69,970
+14,814
+27% +$1.03M
DHI icon
288
D.R. Horton
DHI
$40.8B
$5.33M 0.04%
35,048
+7,175
+26% +$883K
IDXX icon
289
Idexx Laboratories
IDXX
$45B
$5.31M 0.04%
9,559
+2,014
+27% +$946K
VLO icon
290
Valero Energy
VLO
$95.1B
$5.28M 0.04%
40,649
+7,770
+24% +$989K
VEEV icon
291
Veeva Systems
VEEV
$39.2B
$5.27M 0.04%
27,384
+14,137
+107% +$2.66M
MNST icon
292
Monster Beverage
MNST
$90.1B
$5.21M 0.04%
180,882
+38,086
+27% +$1.02M
MSCI icon
293
MSCI
MSCI
$40.9B
$5.15M 0.04%
9,105
+1,827
+25% +$943K
WST icon
294
West Pharmaceutical
WST
$24.8B
$5.11M 0.04%
14,503
+1,755
+14% +$621K
TRV icon
295
Travelers Companies
TRV
$77.2B
$5.02M 0.04%
26,352
+5,352
+25% +$927K
BL icon
296
BlackLine
BL
$1.65B
$5M 0.04%
80,000
NIO icon
297
NIO
NIO
$11.4B
$4.99M 0.04%
550,300
NUE icon
298
Nucor
NUE
$61.7B
$4.98M 0.04%
28,630
+5,789
+25% +$918K
XYZ
299
Block Inc
XYZ
$47B
$4.89M 0.04%
63,258
+13,779
+28% +$779K
IQV icon
300
IQVIA
IQV
$39.8B
$4.88M 0.04%
21,086
+4,206
+25% +$864K

Similar funds

British Columbia Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, British Columbia Investment Management held 818 positions worth $12.2B, up 16% from $10.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

British Columbia Investment Management deployed $440M of net new capital in Q4 2023, opening 13 new positions and adding to 655 existing holdings. Its largest new stake was XP: 510,000 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Canadian Pacific Kansas City, an estimated $131M trimmed.

  • British Columbia Investment Management's largest Q4 2023 buy was XP: 510,000 shares worth $13.3M.
  • British Columbia Investment Management added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, an estimated $97.4M increase.
  • British Columbia Investment Management's biggest Q4 2023 reduction was Canadian Pacific Kansas City, cutting an estimated $131M.
  • British Columbia Investment Management fully exited Open Text in Q4 2023, selling an estimated $7.28M.
  • British Columbia Investment Management's ten largest holdings make up 28% of its $12.2B portfolio in Q4 2023.
  • British Columbia Investment Management opened 13 new positions and closed 35 in Q4 2023.
  • British Columbia Investment Management's portfolio value rose 16% quarter-over-quarter to $12.2B.

Based on British Columbia Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.